Gastroenterology

Hemopure synthetic oxygen solution salvages initially rejected donor livers



Hemoglobin Oxygen Therapeutics announced results from a pilot study of its hemoglobin-based oxygen-carrying solution, Hemopure, in which initially rejected donor livers were salvaged for transplantation, according to a press release.
“The United Network for Organ Sharing (UNOS) estimates that over 13,700 people are currently waiting for a liver transplant nationwide, yet only about 8,250 transplants performed in 2018,” Zafiris Zafirelis, CEO of Hemoglobin Oxygen (HbO2) Therapeutics, said. “Given the significant need to increase donor transplants, the key takeaway from this

Source link

Related posts

P166 MICROBIOME AND EPIGENETIC PREDICTORS OF RESPONSE TO BIOLOGIC THERAPY IN PATIENTS WITH ULCERATIVE COLITIS

Newsemia

Intractable vomiting in a 20-month-old boy

Newsemia

Correction

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy

COVID-19

COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World